Vericel Corp (VCEL)

• Market cap: $1.83B
• 1 day: 0.92%
• 5 days: 1.59%
• 1 month: 20.07%
• 3 months: -8.56%
• 6 months: -11.61%
• Year to date: -34.1%
• 1 year: -15.28%
• 5 years: 78.56%
• 10 years: 1,663.11%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357